Development of Cancer Drugs for Use in Novel Combination - Determining the Contribution of the Individual Drugs’ Effects
Submit Comments by 09/15/2025 Although you can comment on any guidance at any time (see 21 CFR 10.115(g)(5)), to ensure that the FDA considers your comment on a draft guidance before it begins work on the final version of the guidance, submit either online …